Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Intracellular protein trafficking via the endosomes plays a key role in the maintenance of normal neuronal function. Although many diseases of the central nervous system exhibit specific pathological hallmarks, abnormalities of the endosome system are common traits for several of them, including Alzheimer disease (AD). Three main routes originate from the endosomes: the recycling, degradation, and retrograde pathways. Studies have shown that the majority of Down syndrome subjects develop AD pathology and manifest altered morphology and number of endosomes, and abnormalities in lysosome acidification and exosome secretion, suggesting that dysfunction of one of these pathways could play a functional role in the AD‐like phenotype of the syndrome. Two of the major endosomal routes are mediated by the retromer complex, a multimeric system responsible for transport of cargo from the endosome to the trans‐Golgi network or to the cell membrane. Recently, a new endosome system structurally related to the retromer, called “retriever,” has been reported. Whereas we know a great deal about the neuropathophysiology of the retromer complex, no precise pathogenic role for the retriever has yet been identified. Here, we will review the neurobiology of the endosome system and its role as key player in the development of AD‐like pathology in Down syndrome. Additionally, we will discuss current knowledge on these two main endosome systems, retromer and retriever, and their potential as novel therapeutic targets. ANN NEUROL 2021;90:4–14
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments
Chavrier, P., Parton, R. G., Hauri, H. P., Simons, K., & Zerial, M. (1990) · Cell · doi:10.1016/0092-8674(90)90369-p · Cited by 1,166
Clathrin-independent pathways of endocytosis
Mayor, S., Parton, R. G., & Donaldson, J. G. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016758 · Cited by 525
Nixon, R. A. (2017) · The FASEB Journal · doi:10.1096/fj.201700359 · Cited by 400 · cited 1×
“frequently already detected at the fetal stage (28 weeks of gestation).(26) Although morphological changes in the endosomes have been found in postmortem brain tissues of DS patients and in the CNS of Ts65Dn mice (a transgenic mouse model of DS),(27) enlarged endosomes are also observed in the periphery, such as blood…”
BackgroundRetriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346 · cited 1×
“of protein sorting, there are numerous cargoes, including α5β1 integrin, which do not depend on it.(12) This observation indirectly indicated for the first time the existence of an additional system/mechanism working in parallel with the”
BackgroundCooper, J. D., Salehi, A., Delcroix, J.-D., Howe, C. L., Belichenko, P. V., Chua-Couzens, J., Kilbridge, J. F., Carlson, E. J., Epstein, C. J., & Mobley, W. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181219298 · Cited by 336
Kameyama, K., Lee, H.-K., Bear, M. F., & Huganir, R. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80633-9 · Cited by 283
VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology
Wen, L., Tang, F.-L., Hong, Y., Luo, S.-W., Wang, C.-L., He, W., Shen, C., Jung, J.-U., Xiong, F., Lee, D.-H., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201105109 · Cited by 270
Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids
Dickson, E. J., & Hille, B. (2019) · Biochemical Journal · doi:10.1042/bcj20180022 · Cited by 254 · cited 1×
“The first subcellular organelle charged with internalizing of cargoes is the early endosome (EE), a dynamic compartment enriched in phosphoinositide phosphatidylinositol 3-phosphate.(16) The entry into the EE network begins with the endocytosis of integral membrane proteins from the cell surface through clathrin-depen…”
BackgroundCataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 2×
“Interestingly, by morphometric analysis, the number of early endosome-associated protein-1–positive endosomes of all sizes is increased in primary fibroblast from DS patients compared to diploid controls, and the majority of them were identified particularly as large-sized endosomes.(38) In DS retromer complex functio…”
BackgroundGene expression profiling in the adult Down syndrome brain
Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.005 · Cited by 240
Cited by
Jaye, S., Sandau, U. S., & Saugstad, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1378576 · Cited by 26
“This phenomenon is thought to be due to several AD related genes encoded on HSA21, such as APP and PSEN1 (Colacurcio et al., 2018; Jiang et al., 2019; Botté and Potier, 2020; Filippone and Praticò, 2021).”
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, C., Mumford, P., & Wiseman, F. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909669 · Cited by 22
Endosomal recycling defects and neurodevelopmental disorders
Saitoh, S. (2022) · Cells · doi:10.3390/cells11010148 · Cited by 20
Improved mammalian retromer cryo-EM structures reveal a new assembly interface
Kendall, A. K., Chandra, M., Xie, B., Wan, W., & Jackson, L. P. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102523 · Cited by 18
Curtis, M. E., Smith, T., Blass, B. E., & Praticò, D. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12334 · Cited by 4
Self-citation
Metadata
- Authors
- Filippone, A., & Praticò, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2021-02-25
- Volume
- 90
- Issue
- 1
- Pages
- 4-14
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W3126750220
- Cited by
- 20
- References
- 16
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology. https://app.cochat.ai/papers/10.1002/ana.26042
- The paper
- Filippone, A., & Praticò, D. (2021). Endosome Dysregulation in Down Syndrome: A Potential Contributor to Alzheimer Disease Pathology. Annals of Neurology. https://doi.org/10.1002/ana.26042
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.